Back
EviAnnPubMedNew toolBenchmark

Efficient evidence-based genome annotation with EviAnn.

Zimin AV, Puiu D, Pertea M, et al.Nat Methods 2026 · July 2026
Relevance score
8/10
Disease / domain
Evidence-based genome annotation
Source
PubMed
PMID 42399474
Share on LinkedIn

Tool / method

Eukaryotic annotation system building exon-intron structures directly from transcript alignments or protein homology, rather than ab initio predictions

Summary

Machine-learning ab initio annotators long remained central due to scarce expression data. The authors develop EviAnn (Evidence-based Annotator), a strongly data-driven eukaryotic annotation system building exon-intron structures of coding and non-coding genes directly from transcript alignments or protein homology. On identical input, EviAnn outperforms references such as BRAKER3, MAKER2 and FINDER while using far less compute — a mammalian genome is annotated in under an hour on a multicore server. The tool is open source.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A useful incremental improvement in genome annotation, with a clear speed and accuracy gain over references and open-source availability. Its clinical impact is indirect (quality of annotation references), but better annotation underpins all downstream interpretation.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 2/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 8/10

Keywords

genome annotationopen sourcebenchmarktranscriptsprotein homologybioinformatics
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime